Aurobindo Pharma Limited, Unit VII
FDA inspection history in Polepally Jedcherla Mandal, Mahabubnagar, India, 2026
- 1
- Form 483
Every document, by year
- Form 483
2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2026One Form 483, at Polepally Jedcherla Mandal, Mahabubnagar, India.
Cited most
Across all Aurobindo Pharma Limited, Unit VII observations on file
- 21 CFR 211.160General requirements1
- 21 CFR 211.186Master production and control records1
- 21 CFR 211.192Production record review1
- 21 CFR 211.194Laboratory records1
- 21 CFR 211.198Complaint files1
The complete Aurobindo Pharma Limited, Unit VII file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Polepally Jedcherla Mandal, Mahabubnagar, India
One Form 483 · 2026 · 9 observations
Latest: Form 483, Jan 28, 2026 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-01-28 | 483 Form 483 | Polepally Jedcherla Mandal, Mahabubnagar, India | 9 | $99 |
Investigators on these documents
About Aurobindo Pharma Limited, Unit VII
How many FDA Form 483s has Aurobindo Pharma Limited, Unit VII received?
FDA Intel has 1 Form 483 on file for Aurobindo Pharma Limited, Unit VII; the most recent is dated Jan 28, 2026.
When was Aurobindo Pharma Limited, Unit VII last inspected by FDA?
The most recent FDA inspection document on file for Aurobindo Pharma Limited, Unit VII is a Form 483 dated Jan 28, 2026, for the site in Polepally Jedcherla Mandal, Mahabubnagar, India.
What did FDA cite at Aurobindo Pharma Limited, Unit VII?
The regulations cited most in the observations on file for Aurobindo Pharma Limited, Unit VII are 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.186 (Master production and control records), 1 time; 21 CFR 211.192 (Production record review), 1 time.